Vanda Pharmaceuticals Inc. Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Vanda Pharmaceuticals Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • Vanda Pharmaceuticals Inc. Return On Equity for the quarter ending September 30, 2024 was -3.02 %, a 237% decline year-over-year.
  • Vanda Pharmaceuticals Inc. annual Return On Equity for 2023 was 0.46 %, a 62.2% decline from 2022.
  • Vanda Pharmaceuticals Inc. annual Return On Equity for 2022 was 1.22 %, a 82.1% decline from 2021.
  • Vanda Pharmaceuticals Inc. annual Return On Equity for 2021 was 6.81 %, a 27.1% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 0.46 -0.76 -62.2% Jan 1, 2023 Dec 31, 2023
2022 1.22 -5.59 -82.1% Jan 1, 2022 Dec 31, 2022
2021 6.81 +1.45 +27.1% Jan 1, 2021 Dec 31, 2021
2020 5.36 -28 -83.9% Jan 1, 2020 Dec 31, 2020
2019 33.3 +23.5 +240% Jan 1, 2019 Dec 31, 2019
2018 9.8 +21.7 Jan 1, 2018 Dec 31, 2018
2017 -11.9 +2.32 +16.3% Jan 1, 2017 Dec 31, 2017
2016 -14.3 +13.2 +48% Jan 1, 2016 Dec 31, 2016
2015 -27.4 -71.4 -162% Jan 1, 2015 Dec 31, 2015
2014 43.9 +124 Jan 1, 2014 Dec 31, 2014
2013 -79.7 +78.7 +49.7% Jan 1, 2013 Dec 31, 2013
2012 -158 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.